MedPath
HSA Approval

LEVEVITAE FILM-COATED TABLET 500MG

SIN15145P

LEVEVITAE FILM-COATED TABLET 500MG

LEVEVITAE FILM-COATED TABLET 500MG

January 4, 2017

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Licence HolderUNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N03AX14

levetiracetam

Manufacturer Information

UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED

Noucor Health, S.A.

Active Ingredients

LEVETIRACETAM

500mg

Levetiracetam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LEVEVITAE FILM-COATED TABLET 500MG - HSA Approval | MedPath